An open label randomized Phase III trial of nivolumab or nivolumab plus ipilimumab vs platinum doublet chemotherapy (PT-DC) in patients with chemotherapy-naïve stage IV or recurrent non-small cell lung cancer (NSCLC) (CheckMate 227)

التفاصيل البيبلوغرافية
العنوان: An open label randomized Phase III trial of nivolumab or nivolumab plus ipilimumab vs platinum doublet chemotherapy (PT-DC) in patients with chemotherapy-naïve stage IV or recurrent non-small cell lung cancer (NSCLC) (CheckMate 227)
المؤلفون: Hellmann, Matthew, Ramalingam, Suresh, Reck, Martin, O'Byrne, Ken, Paz-Ares, Luis, Harbison, Christopher T, Bhagavatheeswaran, Prabhu, Nathan, Faith, Brahmer, Julie
بيانات النشر: BioMed Central Ltd.
سنة النشر: 2015
المجموعة: BioMed Central
نوع الوثيقة: still image
اللغة: English
العلاقة: http://www.immunotherapyofcancer.org/content/3/S2/P154Test
الإتاحة: http://www.immunotherapyofcancer.org/content/3/S2/P154Test
حقوق: Copyright 2015 Hellmann et al.
رقم الانضمام: edsbas.C21850BD
قاعدة البيانات: BASE